English
简体中文
Total: £ 56.28
Published Date: 2025-06-23 | Pages: 145 | Tables: 147 | Pharma & Healthcare
In 2024, the global market size of Tuberculosis Vaccine Treatment was estimated to be worth US$ 78.3 million and is forecast to reach approximately US$ 95.4 million by 2031 with a CAGR of 2.9% during the forecast period 2025-2031.
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.
In the last several years, global market of Tuberculosis Vaccine Treatment developed smoothly, with an average growth rate of 0.73%.
The classification of Tuberculosis Vaccine Treatment includes Immune Vaccine and Therapy Vaccine, and the proportion of Immune Vaccine in 2019 is about 99.66%.
Tuberculosis Vaccine Treatment is widely sold through Self-Procurement, UNICEF and Other. The most proportion of Tuberculosis Vaccine Treatment is sold through Self-Procurement, and the proportion in 2019 is 62.14%.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 45% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 35.66%.
Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India are the leaders of the industry, they occupy the 60% of the market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Vaccine Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Vaccine Treatment.
The Tuberculosis Vaccine Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tuberculosis Vaccine Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis Vaccine Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Segment by Type
Immune Vaccine
Therapy Vaccine
Segment by Application
Self-Procurement
UNICEF
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Tuberculosis Vaccine Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Tuberculosis Vaccine Treatment manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tuberculosis Vaccine Treatment sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Tuberculosis Vaccine Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 Market by Application
1.3.1 Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Tuberculosis Vaccine Treatment Market Size Estimates and Forecasts
2.1.1 Global Tuberculosis Vaccine Treatment Revenue 2020-2031
2.1.2 Global Tuberculosis Vaccine Treatment Sales 2020-2031
2.2 Tuberculosis Vaccine Treatment Market Size by Region: 2024 Versus 2031
2.3 Tuberculosis Vaccine Treatment Sales by Region (2020-2031)
2.3.1 Global Tuberculosis Vaccine Treatment Sales by Region: 2020-2025
2.3.2 Global Tuberculosis Vaccine Treatment Sales Forecast by Region (2026-2031)
2.3.3 Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2020-2031)
2.4 Tuberculosis Vaccine Treatment Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Tuberculosis Vaccine Treatment Revenue by Region: 2020-2025
2.4.2 Global Tuberculosis Vaccine Treatment Revenue Forecast by Region (2026-2031)
2.4.3 Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Tuberculosis Vaccine Treatment Sales by Type (2020-2031)
3.1.1.1 Global Tuberculosis Vaccine Treatment Sales Volume by Type (2020-2031)
3.1.1.2 Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2020-2031)
3.1.2 Global Tuberculosis Vaccine Treatment Revenue by Type (2020-2031)
3.1.2.1 Global Tuberculosis Vaccine Treatment Revenue by Type (2020-2031)
3.1.2.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2020-2031)
3.1.3 Tuberculosis Vaccine Treatment Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Tuberculosis Vaccine Treatment Sales by Application (2020-2031)
3.2.1.1 Global Tuberculosis Vaccine Treatment Sales Volume by Application (2020-2031)
3.2.1.2 Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2020-2031)
3.2.2 Global Tuberculosis Vaccine Treatment Revenue by Application (2020-2031)
3.2.2.1 Global Tuberculosis Vaccine Treatment Revenue by Application (2020-2031)
3.2.2.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2020-2031)
3.2.3 Tuberculosis Vaccine Treatment Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Immune Vaccine of Tuberculosis Vaccine Treatment Revenue Market Share by Application
3.3.2 Therapy Vaccine of Tuberculosis Vaccine Treatment Revenue Market Share by Application
4 Global Tuberculosis Vaccine Treatment by Manufacturers
4.1 Global Top Tuberculosis Vaccine Treatment Manufacturers by Sales (2020-2025)
4.1.1 Global Tuberculosis Vaccine Treatment Sales by Manufacturer (2020-2025)
4.1.2 Global Tuberculosis Vaccine Treatment Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Tuberculosis Vaccine Treatment Manufacturers by Revenue (2020-2025)
4.2.1 Global Tuberculosis Vaccine Treatment Revenue by Manufacturer (2020-2025)
4.2.2 Global Tuberculosis Vaccine Treatment Revenue Share by Manufacturer (2020-2025)
4.3 Global Tuberculosis Vaccine Treatment Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Tuberculosis Vaccine Treatment Manufacturers Covered: Ranking by Revenue
4.4.2 Global Tuberculosis Vaccine Treatment Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Tuberculosis Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Tuberculosis Vaccine Treatment Manufacturing Base Distribution, Product Type
4.5.1 Tuberculosis Vaccine Treatment Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Tuberculosis Vaccine Treatment Market
4.5.3 Manufacturers Tuberculosis Vaccine Treatment Product Type and Application
4.5.4 Immune Vaccine Market Sales of Tuberculosis Vaccine Treatment by Manufacturer
4.5.5 Therapy Vaccine Market Sales of Tuberculosis Vaccine Treatment by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Merck
5.1.1 Merck Company Information
5.1.2 Merck Description, Business Overview
5.1.3 Merck Tuberculosis Vaccine Treatment Products Offered
5.1.4 Merck Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Merck Tuberculosis Vaccine Treatment Sales by Product in 2024
5.1.6 Merck Tuberculosis Vaccine Treatment Sales by Application in 2024
5.1.7 Merck Tuberculosis Vaccine Treatment Sales by Geographic Area in 2024
5.1.8 Merck Recent Developments
5.2 Japan BCG Lab
5.2.1 Japan BCG Lab Company Information
5.2.2 Japan BCG Lab Description, Business Overview
5.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Products Offered
5.2.4 Japan BCG Lab Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Japan BCG Lab Tuberculosis Vaccine Treatment Sales by Product in 2024
5.2.6 Japan BCG Lab Tuberculosis Vaccine Treatment Sales by Application in 2024
5.2.7 Japan BCG Lab Tuberculosis Vaccine Treatment Sales by Geographic Area in 2024
5.2.8 Japan BCG Lab Recent Developments
5.3 Serum Institute of India
5.3.1 Serum Institute of India Company Information
5.3.2 Serum Institute of India Description, Business Overview
5.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Products Offered
5.3.4 Serum Institute of India Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Serum Institute of India Tuberculosis Vaccine Treatment Sales by Product in 2024
5.3.6 Serum Institute of India Tuberculosis Vaccine Treatment Sales by Application in 2024
5.3.7 Serum Institute of India Tuberculosis Vaccine Treatment Sales by Geographic Area in 2024
5.3.8 Serum Institute of India Recent Developments
5.4 AJ Vaccines
5.4.1 AJ Vaccines Company Information
5.4.2 AJ Vaccines Description, Business Overview
5.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Products Offered
5.4.4 AJ Vaccines Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
5.4.5 AJ Vaccines Tuberculosis Vaccine Treatment Sales by Product in 2024
5.4.6 AJ Vaccines Tuberculosis Vaccine Treatment Sales by Application in 2024
5.4.7 AJ Vaccines Tuberculosis Vaccine Treatment Sales by Geographic Area in 2024
5.4.8 AJ Vaccines Recent Developments
5.5 BioFarma
5.5.1 BioFarma Company Information
5.5.2 BioFarma Description, Business Overview
5.5.3 BioFarma Tuberculosis Vaccine Treatment Products Offered
5.5.4 BioFarma Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
5.5.5 BioFarma Tuberculosis Vaccine Treatment Sales by Product in 2024
5.5.6 BioFarma Tuberculosis Vaccine Treatment Sales by Application in 2024
5.5.7 BioFarma Tuberculosis Vaccine Treatment Sales by Geographic Area in 2024
5.5.8 BioFarma Recent Developments
5.6 GreenSignal Bio Pharma
5.6.1 GreenSignal Bio Pharma Company Information
5.6.2 GreenSignal Bio Pharma Description, Business Overview
5.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Products Offered
5.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
5.6.5 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales by Product in 2024
5.6.6 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales by Application in 2024
5.6.7 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales by Geographic Area in 2024
5.6.8 GreenSignal Bio Pharma Recent Developments
5.7 China National Biotec
5.7.1 China National Biotec Company Information
5.7.2 China National Biotec Description, Business Overview
5.7.3 China National Biotec Tuberculosis Vaccine Treatment Products Offered
5.7.4 China National Biotec Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
5.7.5 China National Biotec Tuberculosis Vaccine Treatment Sales by Product in 2024
5.7.6 China National Biotec Tuberculosis Vaccine Treatment Sales by Application in 2024
5.7.7 China National Biotec Tuberculosis Vaccine Treatment Sales by Geographic Area in 2024
5.7.8 China National Biotec Recent Developments
5.8 Biomed Lublin
5.8.1 Biomed Lublin Company Information
5.8.2 Biomed Lublin Description, Business Overview
5.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Products Offered
5.8.4 Biomed Lublin Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Biomed Lublin Tuberculosis Vaccine Treatment Sales by Product in 2024
5.8.6 Biomed Lublin Tuberculosis Vaccine Treatment Sales by Application in 2024
5.8.7 Biomed Lublin Tuberculosis Vaccine Treatment Sales by Geographic Area in 2024
5.8.8 Biomed Lublin Recent Developments
5.9 Taj Pharmaceuticals
5.9.1 Taj Pharmaceuticals Company Information
5.9.2 Taj Pharmaceuticals Description, Business Overview
5.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Products Offered
5.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales by Product in 2024
5.9.6 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales by Application in 2024
5.9.7 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales by Geographic Area in 2024
5.9.8 Taj Pharmaceuticals Recent Developments
5.10 Ataulpho de Paiva
5.10.1 Ataulpho de Paiva Company Information
5.10.2 Ataulpho de Paiva Description, Business Overview
5.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Products Offered
5.10.4 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales by Product in 2024
5.10.6 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales by Application in 2024
5.10.7 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales by Geographic Area in 2024
5.10.8 Ataulpho de Paiva Recent Developments
5.11 IVAC
5.11.1 IVAC Company Information
5.11.2 IVAC Description, Business Overview
5.11.3 IVAC Tuberculosis Vaccine Treatment Products Offered
5.11.4 IVAC Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
5.11.5 IVAC Tuberculosis Vaccine Treatment Sales by Product in 2024
5.11.6 IVAC Tuberculosis Vaccine Treatment Sales by Application in 2024
5.11.7 IVAC Tuberculosis Vaccine Treatment Sales by Geographic Area in 2024
5.11.8 IVAC Recent Developments
5.12 Queen Saovabha Mem. Inst
5.12.1 Queen Saovabha Mem. Inst Company Information
5.12.2 Queen Saovabha Mem. Inst Description, Business Overview
5.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Products Offered
5.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales by Product in 2024
5.12.6 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales by Application in 2024
5.12.7 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales by Geographic Area in 2024
5.12.8 Queen Saovabha Mem. Inst Recent Developments
5.13 Microgen
5.13.1 Microgen Company Information
5.13.2 Microgen Description, Business Overview
5.13.3 Microgen Tuberculosis Vaccine Treatment Products Offered
5.13.4 Microgen Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Microgen Tuberculosis Vaccine Treatment Sales by Product in 2024
5.13.6 Microgen Tuberculosis Vaccine Treatment Sales by Application in 2024
5.13.7 Microgen Tuberculosis Vaccine Treatment Sales by Geographic Area in 2024
5.13.8 Microgen Recent Developments
6 North America
6.1 North America Tuberculosis Vaccine Treatment Market Size YoY Growth 2020-2031
6.2 North America Tuberculosis Vaccine Treatment Market Facts & Figures by Country
6.2.1 North America Tuberculosis Vaccine Treatment Sales by Country (2020-2031)
6.2.2 North America Tuberculosis Vaccine Treatment Revenue by Country (2020-2031)
6.3 North America Tuberculosis Vaccine Treatment Sales by Type (2020-2025)
6.4 North America Tuberculosis Vaccine Treatment Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Tuberculosis Vaccine Treatment Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Tuberculosis Vaccine Treatment Market Facts & Figures by Region
7.2.1 Asia-Pacific Tuberculosis Vaccine Treatment Sales by Region (2020-2031)
7.2.2 Asia-Pacific Tuberculosis Vaccine Treatment Revenue by Region (2020-2031)
7.3 Asia-Pacific Tuberculosis Vaccine Treatment Sales by Type (2020-2025)
7.4 Asia-Pacific Tuberculosis Vaccine Treatment Sales by Application (2020-2025)
8 Europe
8.1 Europe Tuberculosis Vaccine Treatment Market Size YoY Growth 2020-2031
8.2 Europe Tuberculosis Vaccine Treatment Market Facts & Figures by Country
8.2.1 Europe Tuberculosis Vaccine Treatment Sales by Country (2020-2031)
8.2.2 Europe Tuberculosis Vaccine Treatment Revenue by Country (2020-2031)
8.3 Europe Tuberculosis Vaccine Treatment Sales by Type (2020-2025)
8.4 Europe Tuberculosis Vaccine Treatment Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Tuberculosis Vaccine Treatment Market Size YoY Growth 2020-2031
9.2 Latin America Tuberculosis Vaccine Treatment Market Facts & Figures by Country
9.2.1 Latin America Tuberculosis Vaccine Treatment Sales by Country (2020-2031)
9.2.2 Latin America Tuberculosis Vaccine Treatment Revenue by Country (2020-2031)
9.3 Latin America Tuberculosis Vaccine Treatment Sales by Type (2020-2025)
9.4 Latin America Tuberculosis Vaccine Treatment Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Tuberculosis Vaccine Treatment Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Tuberculosis Vaccine Treatment Market Facts & Figures by Country
10.2.1 Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country (2020-2031)
10.2.2 Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Country (2020-2031)
10.3 Middle East and Africa Tuberculosis Vaccine Treatment Sales by Type (2020-2025)
10.4 Middle East and Africa Tuberculosis Vaccine Treatment Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Tuberculosis Vaccine Treatment Supply Chain Analysis
11.2 Tuberculosis Vaccine Treatment Key Raw Materials and Upstream Suppliers
11.3 Tuberculosis Vaccine Treatment Clients Analysis
11.4 Tuberculosis Vaccine Treatment Sales Channel and Sales Model Analysis
11.4.1 Tuberculosis Vaccine Treatment Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Tuberculosis Vaccine Treatment Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Tuberculosis Vaccine Treatment Distributors
12 Tuberculosis Vaccine Treatment Market Dynamics
12.1 Tuberculosis Vaccine Treatment Industry Trends
12.2 Tuberculosis Vaccine Treatment Market Drivers
12.3 Tuberculosis Vaccine Treatment Market Challenges
12.4 Tuberculosis Vaccine Treatment Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Tuberculosis Vaccine Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Tuberculosis Vaccine Treatment Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Tuberculosis Vaccine Treatment Sales by Region (2020-2025) & (K Dose)
Table 5. Global Tuberculosis Vaccine Treatment Sales Forecast by Region (2026-2031) & (K Dose)
Table 6. Global Tuberculosis Vaccine Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Tuberculosis Vaccine Treatment Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Tuberculosis Vaccine Treatment Sales Volume by Type (2020-2025) & (K Dose)
Table 9. Global Tuberculosis Vaccine Treatment Sales Volume by Type (2026-2031) & (K Dose)
Table 10. Global Tuberculosis Vaccine Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Tuberculosis Vaccine Treatment Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Tuberculosis Vaccine Treatment Sales Volume by Application (2020-2025) & (K Dose)
Table 13. Global Tuberculosis Vaccine Treatment Sales Volume by Application (2026-2031) & (K Dose)
Table 14. Global Tuberculosis Vaccine Treatment Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Tuberculosis Vaccine Treatment Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Tuberculosis Vaccine Treatment Sales by Manufacturer (2020-2025) & (K Dose)
Table 17. Global Tuberculosis Vaccine Treatment Sales Share by Manufacturer (2020-2025)
Table 18. Tuberculosis Vaccine Treatment Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Tuberculosis Vaccine Treatment Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Tuberculosis Vaccine Treatment Price (2020-2025) & (USD/K Dose)
Table 21. Ranking of Global Top Tuberculosis Vaccine Treatment Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Tuberculosis Vaccine Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Tuberculosis Vaccine Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Vaccine Treatment as of 2024)
Table 24. Tuberculosis Vaccine Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Tuberculosis Vaccine Treatment Market
Table 26. Manufacturers Tuberculosis Vaccine Treatment Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Merck Company Information
Table 29. Merck Description and Business Overview
Table 30. Merck Tuberculosis Vaccine Treatment Product
Table 31. Merck Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 32. Merck Sales Proportion of Tuberculosis Vaccine Treatment by Product in 2024
Table 33. Merck Sales Proportion of Tuberculosis Vaccine Treatment by Application in 2024
Table 34. Merck Sales Proportion of Tuberculosis Vaccine Treatment by Geographic Area in 2024
Table 35. Merck Recent Developments
Table 36. Japan BCG Lab Company Information
Table 37. Japan BCG Lab Description and Business Overview
Table 38. Japan BCG Lab Tuberculosis Vaccine Treatment Product
Table 39. Japan BCG Lab Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 40. Japan BCG Lab Sales Proportion of Tuberculosis Vaccine Treatment by Product in 2024
Table 41. Japan BCG Lab Sales Proportion of Tuberculosis Vaccine Treatment by Application in 2024
Table 42. Japan BCG Lab Sales Proportion of Tuberculosis Vaccine Treatment by Geographic Area in 2024
Table 43. Japan BCG Lab Recent Developments
Table 44. Serum Institute of India Company Information
Table 45. Serum Institute of India Description and Business Overview
Table 46. Serum Institute of India Tuberculosis Vaccine Treatment Product
Table 47. Serum Institute of India Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 48. Serum Institute of India Sales Proportion of Tuberculosis Vaccine Treatment by Product in 2024
Table 49. Serum Institute of India Sales Proportion of Tuberculosis Vaccine Treatment by Application in 2024
Table 50. Serum Institute of India Sales Proportion of Tuberculosis Vaccine Treatment by Geographic Area in 2024
Table 51. Serum Institute of India Recent Developments
Table 52. AJ Vaccines Company Information
Table 53. AJ Vaccines Description and Business Overview
Table 54. AJ Vaccines Tuberculosis Vaccine Treatment Product
Table 55. AJ Vaccines Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 56. AJ Vaccines Sales Proportion of Tuberculosis Vaccine Treatment by Product in 2024
Table 57. AJ Vaccines Sales Proportion of Tuberculosis Vaccine Treatment by Application in 2024
Table 58. AJ Vaccines Sales Proportion of Tuberculosis Vaccine Treatment by Geographic Area in 2024
Table 59. AJ Vaccines Recent Developments
Table 60. BioFarma Company Information
Table 61. BioFarma Description and Business Overview
Table 62. BioFarma Tuberculosis Vaccine Treatment Product
Table 63. BioFarma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 64. BioFarma Sales Proportion of Tuberculosis Vaccine Treatment by Product in 2024
Table 65. BioFarma Sales Proportion of Tuberculosis Vaccine Treatment by Application in 2024
Table 66. BioFarma Sales Proportion of Tuberculosis Vaccine Treatment by Geographic Area in 2024
Table 67. BioFarma Recent Developments
Table 68. GreenSignal Bio Pharma Company Information
Table 69. GreenSignal Bio Pharma Description and Business Overview
Table 70. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product
Table 71. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 72. GreenSignal Bio Pharma Sales Proportion of Tuberculosis Vaccine Treatment by Product in 2024
Table 73. GreenSignal Bio Pharma Sales Proportion of Tuberculosis Vaccine Treatment by Application in 2024
Table 74. GreenSignal Bio Pharma Sales Proportion of Tuberculosis Vaccine Treatment by Geographic Area in 2024
Table 75. GreenSignal Bio Pharma Recent Developments
Table 76. China National Biotec Company Information
Table 77. China National Biotec Description and Business Overview
Table 78. China National Biotec Tuberculosis Vaccine Treatment Product
Table 79. China National Biotec Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 80. China National Biotec Sales Proportion of Tuberculosis Vaccine Treatment by Product in 2024
Table 81. China National Biotec Sales Proportion of Tuberculosis Vaccine Treatment by Application in 2024
Table 82. China National Biotec Sales Proportion of Tuberculosis Vaccine Treatment by Geographic Area in 2024
Table 83. China National Biotec Recent Developments
Table 84. Biomed Lublin Company Information
Table 85. Biomed Lublin Description and Business Overview
Table 86. Biomed Lublin Tuberculosis Vaccine Treatment Product
Table 87. Biomed Lublin Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 88. Biomed Lublin Sales Proportion of Tuberculosis Vaccine Treatment by Product in 2024
Table 89. Biomed Lublin Sales Proportion of Tuberculosis Vaccine Treatment by Application in 2024
Table 90. Biomed Lublin Sales Proportion of Tuberculosis Vaccine Treatment by Geographic Area in 2024
Table 91. Biomed Lublin Recent Developments
Table 92. Taj Pharmaceuticals Company Information
Table 93. Taj Pharmaceuticals Description and Business Overview
Table 94. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product
Table 95. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 96. Taj Pharmaceuticals Sales Proportion of Tuberculosis Vaccine Treatment by Product in 2024
Table 97. Taj Pharmaceuticals Sales Proportion of Tuberculosis Vaccine Treatment by Application in 2024
Table 98. Taj Pharmaceuticals Sales Proportion of Tuberculosis Vaccine Treatment by Geographic Area in 2024
Table 99. Taj Pharmaceuticals Recent Developments
Table 100. Ataulpho de Paiva Company Information
Table 101. Ataulpho de Paiva Description and Business Overview
Table 102. Ataulpho de Paiva Tuberculosis Vaccine Treatment Product
Table 103. Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 104. Ataulpho de Paiva Sales Proportion of Tuberculosis Vaccine Treatment by Product in 2024
Table 105. Ataulpho de Paiva Sales Proportion of Tuberculosis Vaccine Treatment by Application in 2024
Table 106. Ataulpho de Paiva Sales Proportion of Tuberculosis Vaccine Treatment by Geographic Area in 2024
Table 107. Ataulpho de Paiva Recent Developments
Table 108. IVAC Company Information
Table 109. IVAC Description and Business Overview
Table 110. IVAC Tuberculosis Vaccine Treatment Product
Table 111. IVAC Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 112. IVAC Sales Proportion of Tuberculosis Vaccine Treatment by Product in 2024
Table 113. IVAC Sales Proportion of Tuberculosis Vaccine Treatment by Application in 2024
Table 114. IVAC Sales Proportion of Tuberculosis Vaccine Treatment by Geographic Area in 2024
Table 115. IVAC Recent Developments
Table 116. Queen Saovabha Mem. Inst Company Information
Table 117. Queen Saovabha Mem. Inst Description and Business Overview
Table 118. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product
Table 119. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 120. Queen Saovabha Mem. Inst Sales Proportion of Tuberculosis Vaccine Treatment by Product in 2024
Table 121. Queen Saovabha Mem. Inst Sales Proportion of Tuberculosis Vaccine Treatment by Application in 2024
Table 122. Queen Saovabha Mem. Inst Sales Proportion of Tuberculosis Vaccine Treatment by Geographic Area in 2024
Table 123. Queen Saovabha Mem. Inst Recent Developments
Table 124. Microgen Company Information
Table 125. Microgen Description and Business Overview
Table 126. Microgen Tuberculosis Vaccine Treatment Product
Table 127. Microgen Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 128. Microgen Sales Proportion of Tuberculosis Vaccine Treatment by Product in 2024
Table 129. Microgen Sales Proportion of Tuberculosis Vaccine Treatment by Application in 2024
Table 130. Microgen Sales Proportion of Tuberculosis Vaccine Treatment by Geographic Area in 2024
Table 131. Microgen Recent Developments
Table 132. North America Tuberculosis Vaccine Treatment Sales by Country (2020-2025) & (K Dose)
Table 133. North America Tuberculosis Vaccine Treatment Sales by Country (2026-2031) & (K Dose)
Table 134. North America Tuberculosis Vaccine Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 135. North America Tuberculosis Vaccine Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 136. North America Tuberculosis Vaccine Treatment Sales by Type (2020-2025) & (K Dose)
Table 137. North America Tuberculosis Vaccine Treatment Sales by Application (2020-2025) & (K Dose)
Table 138. Asia-Pacific Tuberculosis Vaccine Treatment Sales by Region (2020-2025) & (K Dose)
Table 139. Asia-Pacific Tuberculosis Vaccine Treatment Sales by Region (2026-2031) & (K Dose)
Table 140. Asia-Pacific Tuberculosis Vaccine Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 141. Asia-Pacific Tuberculosis Vaccine Treatment Revenue by Region (2026-2031) & (US$ Million)
Table 142. Asia-Pacific Tuberculosis Vaccine Treatment Sales by Type (2020-2025) & (K Dose)
Table 143. Asia-Pacific Tuberculosis Vaccine Treatment Sales by Application (2020-2025) & (K Dose)
Table 144. Europe Tuberculosis Vaccine Treatment Sales by Country (2020-2025) & (K Dose)
Table 145. Europe Tuberculosis Vaccine Treatment Sales by Country (2026-2031) & (K Dose)
Table 146. Europe Tuberculosis Vaccine Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 147. Europe Tuberculosis Vaccine Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 148. Europe Tuberculosis Vaccine Treatment Sales by Type (2020-2025) & (K Dose)
Table 149. Europe Tuberculosis Vaccine Treatment Sales by Application (2020-2025) & (K Dose)
Table 150. Latin America Tuberculosis Vaccine Treatment Sales by Country (2020-2025) & (K Dose)
Table 151. Latin America Tuberculosis Vaccine Treatment Sales by Country (2026-2031) & (K Dose)
Table 152. Latin America Tuberculosis Vaccine Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 153. Latin America Tuberculosis Vaccine Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 154. Latin America Tuberculosis Vaccine Treatment Sales by Type (2020-2025) & (K Dose)
Table 155. Latin America Tuberculosis Vaccine Treatment Sales by Application (2020-2025) & (K Dose)
Table 156. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country (2020-2025) & (K Dose)
Table 157. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country (2026-2031) & (K Dose)
Table 158. Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 159. Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 160. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Type (2020-2025) & (K Dose)
Table 161. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Application (2020-2025) & (K Dose)
Table 162. Tuberculosis Vaccine Treatment Key Raw Materials, Industry Status and Trend
Table 163. Tuberculosis Vaccine Treatment Key Raw Materials and Upstream Suppliers
Table 164. Tuberculosis Vaccine Treatment Clients Status and Trend
Table 165. Tuberculosis Vaccine Treatment Typical Clients
Table 166. Tuberculosis Vaccine Treatment Distributors
Table 167. Tuberculosis Vaccine Treatment Market Trends
Table 168. Tuberculosis Vaccine Treatment Market Drivers
Table 169. Tuberculosis Vaccine Treatment Market Challenges
Table 170. Tuberculosis Vaccine Treatment Market Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
Table 174. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Tuberculosis Vaccine Treatment Product Picture
Figure 2. Global Tuberculosis Vaccine Treatment Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Tuberculosis Vaccine Treatment Sales Market Share by Type in 2024 & 2031
Figure 4. Immune Vaccine Product Picture
Figure 5. Therapy Vaccine Product Picture
Figure 6. Global Tuberculosis Vaccine Treatment Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Tuberculosis Vaccine Treatment Sales Market Share by Application in 2024 & 2031
Figure 8. Self-Procurement
Figure 9. UNICEF
Figure 10. Other
Figure 11. Tuberculosis Vaccine Treatment Report Years Considered
Figure 12. Global Tuberculosis Vaccine Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Tuberculosis Vaccine Treatment Market Size 2020-2031 (US$ Million)
Figure 14. Global Tuberculosis Vaccine Treatment Sales 2020-2031 (K Dose)
Figure 15. Global Tuberculosis Vaccine Treatment Sales Market Share Forecast by Region (2020-2031)
Figure 16. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2020-2031)
Figure 17. Global Tuberculosis Vaccine Treatment Sales Market Share Forecast by Type (2020-2031)
Figure 18. Global Tuberculosis Vaccine Treatment Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Tuberculosis Vaccine Treatment Average Selling Price (ASP) by Type (2020-2025) & (USD/K Dose)
Figure 20. Global Tuberculosis Vaccine Treatment Sales Market Share Forecast by Application (2020-2031)
Figure 21. Global Tuberculosis Vaccine Treatment Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Tuberculosis Vaccine Treatment Average Selling Price (ASP) by Application (2020-2025) & (USD/K Dose)
Figure 23. Immune Vaccine of Tuberculosis Vaccine Treatment Revenue Market Share by Application, 2024 VS 2031
Figure 24. Therapy Vaccine of Tuberculosis Vaccine Treatment Revenue Market Share by Application, 2024 VS 2031
Figure 25. Global Tuberculosis Vaccine Treatment Sales Share by Manufacturer in 2024
Figure 26. Tuberculosis Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Immune Vaccine Market Sales Proportion by Manufacturer in 2024
Figure 28. Therapy Vaccine Market Sales Proportion by Manufacturer in 2024
Figure 29. North America Tuberculosis Vaccine Treatment Revenue 2020-2031 (US$ Million)
Figure 30. North America Tuberculosis Vaccine Treatment Sales Market Share by Type (2020-2025)
Figure 31. North America Tuberculosis Vaccine Treatment Sales Market Share by Application (2020-2025)
Figure 32. Asia-Pacific Tuberculosis Vaccine Treatment Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Tuberculosis Vaccine Treatment Sales Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Tuberculosis Vaccine Treatment Revenue Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Tuberculosis Vaccine Treatment Sales Market Share by Type (2020-2025)
Figure 36. Asia-Pacific Tuberculosis Vaccine Treatment Sales Market Share by Application (2020-2025)
Figure 37. Europe Tuberculosis Vaccine Treatment Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Europe Tuberculosis Vaccine Treatment Sales Market Share by Country (2020-2031)
Figure 39. Europe Tuberculosis Vaccine Treatment Revenue Market Share by Country (2020-2031)
Figure 40. Europe Tuberculosis Vaccine Treatment Sales Market Share by Type (2020-2025)
Figure 41. Europe Tuberculosis Vaccine Treatment Sales Market Share by Application (2020-2025)
Figure 42. Latin America Tuberculosis Vaccine Treatment Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Latin America Tuberculosis Vaccine Treatment Sales Market Share by Country (2020-2031)
Figure 44. Latin America Tuberculosis Vaccine Treatment Revenue Market Share by Country (2020-2025)
Figure 45. Latin America Tuberculosis Vaccine Treatment Sales Market Share by Type (2020-2025)
Figure 46. Latin America Tuberculosis Vaccine Treatment Sales Market Share by Application (2020-2025)
Figure 47. Middle East and Africa Tuberculosis Vaccine Treatment Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa Tuberculosis Vaccine Treatment Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Tuberculosis Vaccine Treatment Revenue Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Tuberculosis Vaccine Treatment Sales Market Share by Type (2020-2025)
Figure 51. Middle East and Africa Tuberculosis Vaccine Treatment Sales Market Share by Application (2020-2025)
Figure 52. Tuberculosis Vaccine Treatment Supply Chain (Upstream and Downstream Market)
Figure 53. Global Production Market Share of Tuberculosis Vaccine Treatment Raw Materials by Region in 2024
Figure 54. Tuberculosis Vaccine Treatment Distribution Channels
Figure 55. Global Tuberculosis Vaccine Treatment Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 56. Global Tuberculosis Vaccine Treatment Percentage 2020-2031: Online Sales VS Offline Sales
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
